Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Gastrointestinal Stromal Tumors 71Sarcoma 12Brain Neoplasms 10Gliosarcoma 9Glioblastoma 9Neoplasm Metastasis 6Glioma 6Dermatofibrosarcoma 6Oligodendroglioma 5Central Nervous System Neoplasms 5Astrocytoma 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Fibrosarcoma 4Chordoma 4Sarcoma, Synovial 3Osteosarcoma 3Neurofibrosarcoma 3Neuroectodermal Tumors, Primitive, Peripheral 3Neoplasms 3Liposarcoma 3Hemangiosarcoma 3Glioma, Subependymal 3Digestive System Neoplasms 3Desmoid Tumors 3Sarcoma, Endometrial Stromal 2Recurrence 2Primary Myelofibrosis 2Piebaldism 2Multiple Myeloma 2Meningioma 2

Interventions

liposomal doxorubicin 3Paclitaxel 3Thalidomide 2Semaxinib 2Polymerase Chain Reaction 2Filgrastim 2Etoposide 2Docetaxel 2Daunorubicin 2valspodar 1nirogacestat 1halofuginone 1etoposide phosphate 1entinostat 1emvododstat 1efineptakin alfa 1Valproic Acid 1Sunitinib 1Sirolimus 1Saquinavir 1SUB1 protein, human 1Ritonavir 1Peripheral Blood Stem Cell Transplantation 1Palliative Care 1Nutritional Support 1Nelfinavir 1N-((2S)-2-mercapto-1-oxo-4-(3,4,4- trimethyl-2,5-dioxo-1-imidazolidinyl)butyl)-L-leucyl-N,3- dimethyl-L-Valinamide 1Lenalidomide 1Interleukin-12 Subunit p35 1Interleukin-12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
AIDS-related Kaposi sarcoma × Imatinib Mesylate × Sarcoma × Clear all
NCT00090987 2018-06-06

Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma

AIDS Malignancy Consortium

Phase 2 Completed
30 enrolled 7 charts
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡